| ORIGINAL ARTICLE
|Year : 2016 | Volume
| Issue : 2 | Page : 125--129
Profile of malignant spinal cord compression: One year study at regional cancer center
Malik Tariq Rasool1, Kaneez Fatima1, Najmi Arshad Manzoor1, Syed Arshad Mustafa2, Lone Mohammad Maqbool1, Wani Shaqul Qamar1, Fir Afroz1, Nazir Ahmad Khan1, Saqib Ahmad Shah1, Manan Shah1
1 Department of Radiation Oncology, Regional Cancer Centre, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
2 Department of Radiation Oncology, Government Medical College, Srinagar, Jammu and Kashmir, India
Background and Objectives: Malignant spinal cord compression is an oncologic emergency, unless diagnosed early and treated appropriately, can lead to permanent neurological impairment and compromised quality of life of patients. We analyzed the epidemiology and the effect of common interventions on the outcome in these patients.
Patients and Methods: We conducted a prospective study of 77 patients in the year 2014 and recorded relevant patient and disease characteristics. All patients received corticosteroids. Eight patients were operated upon, and radiotherapy was delivered in 62 patients.
Results: Most of the patients were in the age group of 41–60 years and there was no gender preponderance in patients. Female breast cancer was the most common incident (15.5%) malignancy followed by multiple myeloma, lung, and prostatic carcinoma. Lower dorsal spine was the most common site of compression (35%) followed by lumbar (31%) and mid-dorsal (26%) spine. 70 (91%) patients had cord compression subsequent to bone metastasis while as other patients had leptomeningeal metastasis. In 31 (40%) patients, spinal cord compression was the presenting symptom. Overall, only 26 patients had motor improvement after treatment.
Conclusion: Grade of power before treatment was predictive of response to treatment and overall outcome of motor or sensory functions. Neurodeficit of more than 10 days duration was associated with poor outcome in neurological function.
Malik Tariq Rasool
Department of Radiation Oncology, Regional Cancer Centre, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*